Bolt Biotherapeutics, Inc. (BOLT) vs COSCIENS Biopharma Inc. (CSCIF)
- Bolt Biotherapeutics, Inc. BOLT 4.06 −4.25%
- COSCIENS Biopharma Inc. CSCIF 6.49 +3.84%
Bolt Biotherapeutics, Inc. and COSCIENS Biopharma Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and COSCIENS Biopharma Inc. are of similar size ($8.6M and $8.2M). Bolt Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −3.02%. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs −611.5%) and the higher return on invested capital (−40.6% vs −143.8%). Across the 18 metrics below, COSCIENS Biopharma Inc. leads on 13 and Bolt Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | BOLT | CSCIF | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 46.48% | 65.16% |
| Operating margin | (654.53%) | (71.13%) | 0.00% |
| Net margin | (611.47%) | 75.11% | 0.00% |
| Free cash flow margin | (655.72%) | (40.36%) | 0.00% |
| Return on equity | (111.65%) | 59.74% | (56.36%) |
| Return on assets | (49.62%) | 28.24% | (48.04%) |
| Return on invested capital | (143.75%) | (40.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack